Fund 1 Investments LLC Takes Position in Tempus AI, Inc. $TEM

Fund 1 Investments LLC bought a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the second quarter, HoldingsChannel.com reports. The institutional investor bought 25,000 shares of the company’s stock, valued at approximately $1,588,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in TEM. Concord Wealth Partners boosted its holdings in Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock valued at $26,000 after acquiring an additional 308 shares in the last quarter. Allworth Financial LP lifted its position in shares of Tempus AI by 5,000.0% in the 2nd quarter. Allworth Financial LP now owns 459 shares of the company’s stock worth $29,000 after purchasing an additional 450 shares during the period. SouthState Corp lifted its position in shares of Tempus AI by 3,761.5% in the 2nd quarter. SouthState Corp now owns 502 shares of the company’s stock worth $32,000 after purchasing an additional 489 shares during the period. Quarry LP bought a new stake in shares of Tempus AI during the 1st quarter valued at about $44,000. Finally, EverSource Wealth Advisors LLC increased its position in shares of Tempus AI by 88.8% during the second quarter. EverSource Wealth Advisors LLC now owns 691 shares of the company’s stock valued at $44,000 after buying an additional 325 shares during the period. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. BTIG Research raised their price objective on shares of Tempus AI from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. HC Wainwright decreased their target price on Tempus AI from $98.00 to $89.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Canaccord Genuity Group lowered their target price on Tempus AI from $110.00 to $95.00 and set a “buy” rating for the company in a research note on Wednesday, November 5th. Morgan Stanley lifted their price target on Tempus AI from $80.00 to $85.00 and gave the company an “overweight” rating in a research report on Monday, December 1st. Finally, Cowen downgraded Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $83.09.

Insider Transactions at Tempus AI

In related news, CFO James William Rogers sold 19,966 shares of the company’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $73.20, for a total value of $1,461,511.20. Following the transaction, the chief financial officer owned 111,250 shares in the company, valued at $8,143,500. The trade was a 15.22% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the firm’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $74.10, for a total transaction of $12,319,125.00. Following the sale, the chief executive officer owned 9,008,033 shares of the company’s stock, valued at approximately $667,495,245.30. This represents a 1.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 1,097,780 shares of company stock valued at $86,054,406. 26.27% of the stock is currently owned by corporate insiders.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $70.61 on Friday. The company has a 50 day simple moving average of $80.97 and a two-hundred day simple moving average of $73.39. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32. The company has a market capitalization of $12.56 billion, a price-to-earnings ratio of -59.34 and a beta of 4.99. The company has a debt-to-equity ratio of 2.45, a quick ratio of 3.12 and a current ratio of 3.28.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.05. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The company had revenue of $334.21 million for the quarter, compared to the consensus estimate of $328.89 million. During the same quarter in the prior year, the business posted ($0.46) EPS. The firm’s quarterly revenue was up 84.7% compared to the same quarter last year. Analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.